MIRA Pharmaceuticals, Inc. (MIRA) Stock Statistics & Valuation Metrics

MIRA Pharmaceuticals, Inc. has a market cap or net worth of $46.64M. The enterprise value is $40.14M.

MIRA Pharmaceuticals, Inc. has 42,022,087 shares outstanding. The number of shares has decreased by -2.65% in one year.

MIRA Pharmaceuticals, Inc.’s return on equity (ROE) is -1.00 and return on invested capital (ROIC) is -100.98%.

The current PE Ratio of MIRA Pharmaceuticals, Inc. is ―. MIRA Pharmaceuticals, Inc.’s PEG ratio is -0.02.

In the last 12 months, MIRA Pharmaceuticals, Inc. had revenue of 0.00 and earned -10.44M in profits. Earnings per share was -1.35.

In the last 12 months, operating cash flow was -4.66M and capital expenditures 1.00, giving a free cash flow of -4.66M billion.

MIRA Pharmaceuticals, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

MIRA Pharmaceuticals, Inc. upcoming earnings date is ―, ―.

MIRA Pharmaceuticals, Inc. as a current ratio of 15.75, with Debt / Equity ratio of 0.00%

In the past 12 months, MIRA Pharmaceuticals, Inc. has paid 0.00 in taxes.

MIRA Pharmaceuticals, Inc. EV to EBITDA ratio is -2.80, with an EV/FCF ratio of -6.31.

MIRA Pharmaceuticals, Inc. has $6.35M in cash and marketable securities with $0.00 in debt, giving a net cash position of $6.35M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for MIRA Pharmaceuticals, Inc. is $8.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy